|
Symbol
|
P322TQ | VOWLTQ | WEVLTQ | WXNLTQ | LVBVLK | EOJRCH | RMABXV | YOTLTQ | RMBWDV | RMAVSV | RMAXKV | BTJBKB | ZPRLTQ | OCGRCH | LTHCLK | AAHUTQ | ONFRCH | RMBE8V | OOJRCH | AAIETQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | LUKB Autocallable Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | Multi Vonti | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Reverse Convertible |
|
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Apple Inc. / Coca-Cola Co. / LVMH Moet Hennessy Louis Vuitton / Nestlé S.A. / UNILEVER TMICC BASKET | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé S.A. / Swatch Group I / Swiss Life Hldg. N / Swiss RE AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS / UBS / Zurich | Holcim/Amrize Basket / Kühne & Nagel Intl. AG / Nestlé S.A. / Novartis AG / Roche AG | Holcim/Amrize Basket / Nestlé S.A. / Novartis AG / Swiss RE AG / Zurich Insurance Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | ABB N / Nestlé N / Novartis N / Roche GS / Swiss RE AG | Danone S.A. / Kraft Heinz Co. / Nestlé N | Barry Callebaut AG / Nestlé S.A. / SGS S.A. Ltd. | Nestlé / Novartis | Barry Callebaut AG / Nestlé S.A. / Roche AG / Swiss RE AG / UBS Group AG | Nestlé / Novartis / Roche GS |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
23.12.2025 | 23.12.2027 | 31.03.2028 | 30.06.2028 | 20.07.2026 | 14.01.2026 | 12.10.2026 | 24.11.2027 | 27.07.2026 | 23.02.2026 | 23.03.2026 | 08.04.2027 | 23.04.2027 | 26.04.2027 | 09.07.2027 | 22.07.2026 | 08.04.2026 | 13.07.2026 | 15.07.2026 | 19.07.2027 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
66,90 | 87,43 | 71,27 | 58,95 | 333,19 | 188,09 | 77,13 | 74,2425 | 158,67 | 47,42 | 59,95 | 13,87 | 12,765 | 136,524 | 31,6224 | 40,46 | 1 098,00 | 83,70 | 997,10 | 52,063 |
| rendement max. p.a. | 116,31% | 6,68% | 5,12% | 6,54% | 25,19% | -2,20% | 9,67% | 6,06% | 4,39% | 60,60% | 3,34% | 3,78% | 3,10% | 4,25% | 5,21% | - | 18,62% | 20,45% | 11,53% | 1,34% |
| Demande | 98,94 | - | 100,59 | 94,47 | - | 100,67 | 95,90 | 96,05 | 100,00 | 79,00 | 100,20 | - | 103,27 | - | - | 97,11 | - | 92,00 | 96,38 | - |
| Offre | 99,74 | - | 101,40 | 95,27 | - | 101,48 | 96,70 | 96,85 | 101,00 | 86,00 | 101,20 | - | 104,10 | - | - | - | - | 93,00 | 97,18 | - |